#USA #New York #Class Action #Securities Fraud #Zynex Inc.

Zynex, Inc. Investors to Act Responsively Ahead of Deadline

In a pivotal move for Zynex, Inc. (OTC PINK: ZYXIQ) shareholders, the law firm Levi & Korsinsky, LLP has issued a reminder regarding the critical lead plaintiff deadline, which is set for April 21, 2026. This deadline comes in light of an ongoing class action securities lawsuit that claims significant losses suffered by investors due to alleged fraudulent activities, including securities fraud, orchestrated between February 25, 2021, and December 15, 2025.

Overview of the Lawsuit

The allegations in this class action lawsuit are extensive and detail serious misconduct by Zynex's management. According to the complaint, the company engaged in practices that included shipping excessive products, leading to inflated revenue figures. Additionally, these actions have reportedly drawn the attention of health insurers, including the military health insurance program, Tricare, inciting further legal scrutiny against the company.

In August 2023, an urgent development unfolded when Travelers, a major insurance provider, initiated legal proceedings against Zynex and its executives, accusing them of executing a fraudulent overbilling scheme. This lawsuit seeks over $23 million in damages for multiple fraudulent claims filed during the years 2018 to 2023. The allegations suggest a systematic breach of trust that exploited not only health insurer policies but also potentially violated federal regulations.

Defendants Allegations

Among the key accusations are:

• - Zynex's management allegedly prioritized aggressive sales tactics at the expense of adherence to legal standards.
• - The audit committee allegedly supported these schemes by endorsing stock repurchase plans, intentionally misleading the stock market regarding Zynex’s financial stability.
• - A troubling pattern emerged regarding orders that were reportedly driven not by genuine demand but by unethical billing practices.

What Should Shareholders Do?

For investors who suffered losses during the specified time period, it is crucial to act before the April 21, 2026 deadline. Appointing oneself as a lead plaintiff not only facilitates participation in any potential recovery but also strengthens the overall case against the defendants involved in the scandal. Importantly, participation does not require one to serve as the lead plaintiff, thus allowing multiple investors to collaborate in holding the company accountable for its actions.

If you wish to learn more about your legal rights or want to take action, you should contact Levi & Korsinsky’s legal team directly. They offer to assist affected shareholders at no cost, ensuring that participation doesn’t burden investors with out-of-pocket expenses.

Why Levi & Korsinsky?

As a firm that has successfully recouped hundreds of millions for its clients over the past two decades, Levi & Korsinsky stands out for its specialized focus on securities litigation. Recognized in ISS Securities Class Action Services' Top 50 report, their legal team, composed of over 70 experts, is well-equipped to navigate complex securities matters. Their track record provides confidence for potential plaintiffs looking for a dedicated partner in navigating this challenging legal landscape.

Contact Information

Shareholders interested in pursuing this opportunity can reach out using the following contact details:

• - Email: [email protected]
• - Phone: (212) 363-7500

In summary, with the looming deadline to act on the Zynex litigation, affected investors are urged to seek legal guidance promptly. This lawsuit offers a chance for recovery and justice against alleged securities fraud that has significantly impacted their financial interests.